Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 213
Gene Symbol: ALB
ALB
0.390 Biomarker disease CTD_human Kinetics of adaptive immunity to cationic bovine serum albumin-induced membranous nephropathy. 17622271 2007
Entrez Id: 213
Gene Symbol: ALB
ALB
0.390 Biomarker disease BEFREE It is remarkable that experimental models such as Heymann nephritis and cationic bovine serum albumin-induced MN in the rabbit predicted the pathomechanisms of the human glomerulopathy. 28597189 2017
Entrez Id: 213
Gene Symbol: ALB
ALB
0.390 Biomarker disease CTD_human Mouse model of membranous nephropathy induced by cationic bovine serum albumin: antigen dose-response relations and strain differences. 15385633 2004
Entrez Id: 10541
Gene Symbol: ANP32B
ANP32B
0.010 AlteredExpression disease BEFREE BAFF and APRIL expression as an autoimmune signature of membranous nephropathy. 29423047 2018
Entrez Id: 335
Gene Symbol: APOA1
APOA1
0.300 Biomarker disease CTD_human Apolipoprotein AI levels are increased in part as a consequence of reduced catabolism in nephrotic rats. 7900854 1995
Entrez Id: 348
Gene Symbol: APOE
APOE
0.210 Biomarker disease RGD Proteinuria decreases tissue lipoprotein receptor levels resulting in altered lipoprotein structure and increasing lipid levels. 22785171 2012
Entrez Id: 348
Gene Symbol: APOE
APOE
0.210 Biomarker disease BEFREE Finally, immunofluorescence demonstrated the absence of apoE in sclerotic glomeruli, while comparably nephrotic patients with membranous nephropathy had an increased glomerular expression of apoE. 12631135 2003
Entrez Id: 350
Gene Symbol: APOH
APOH
0.010 Biomarker disease BEFREE Anti-β2-GPI antibody may play a role in the progression of MN, and this process might involve classic complement activation. 31454804 2019
Entrez Id: 8542
Gene Symbol: APOL1
APOL1
0.010 GeneticVariation disease BEFREE Other conditions where APOL1 variants affect outcomes include membranous nephropathy, lupus nephritis, diabetic nephropathy, preeclampsia, and kidney transplant. 30624253 2019
Entrez Id: 84446
Gene Symbol: BRSK1
BRSK1
0.010 Biomarker disease BEFREE Both Peripheral Blood and Urinary miR-195-5p, miR-192-3p, miR-328-5p and Their Target Genes PPM1A, RAB1A and BRSK1 May Be Potential Biomarkers for Membranous Nephropathy. 30865617 2019
Entrez Id: 56244
Gene Symbol: BTNL2
BTNL2
0.100 GeneticVariation disease GWASCAT Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. 21323541 2011
Entrez Id: 718
Gene Symbol: C3
C3
0.500 Biomarker disease CTD_human Resveratrol ameliorates renal damage, increases expression of heme oxygenase-1, and has anti-complement, anti-oxidative, and anti-apoptotic effects in a murine model of membranous nephropathy. 25954969 2015
Entrez Id: 718
Gene Symbol: C3
C3
0.500 Biomarker disease RGD Treatment with mycophenolate mofetil attenuates the development of Heymann nephritis. 10729746 2000
Entrez Id: 728
Gene Symbol: C5AR1
C5AR1
0.010 Biomarker disease BEFREE Immunohistochemistry and nonradioactive in situ hybridization for C5aR were performed in 34 tissue samples of kidneys from patients with various renal diseases, including 4 with minimal change nephrotic syndrome (MCNS), 5 with membranous nephropathy (MN), and 25 with mesangial proliferative glomerulonephritis (mesGN; 15 patients with IgA nephropathy, 5 with non-IgA mesGN, and 5 with lupus nephritis). 11422745 2001
Entrez Id: 730
Gene Symbol: C7
C7
0.200 Biomarker disease RGD Detection of terminal complement components in experimental immune glomerular injury. 6241952 1984
Entrez Id: 23523
Gene Symbol: CABIN1
CABIN1
0.010 Biomarker disease BEFREE The most common biopsy findings were therapy-related changes with thrombotic microangiopathy (n = 5), calcineurin inhibitor toxicity (n = 4), and membranous glomerulonephritis (n = 3), representing the majority of cases in this category. 29155318 2018
Entrez Id: 6347
Gene Symbol: CCL2
CCL2
0.010 AlteredExpression disease BEFREE Increased glomerular Fn14 and MCP-1 mRNA was confirmed in a second focal segmental glomerulosclerosis cohort and was also observed in membranous nephropathy. 23999007 2013
Entrez Id: 1490
Gene Symbol: CCN2
CCN2
0.010 AlteredExpression disease BEFREE The percentage of cells positive for CTGF mRNA was significantly higher in DN and IgA-N than in MN, MCNS and NHK. 15012739 2003
Entrez Id: 1235
Gene Symbol: CCR6
CCR6
0.010 Biomarker disease BEFREE CCR6- and CD20-positive B cells were localized in renal biopsies with IgA nephropathy (n = 13), membranous nephropathy (n = 12), crescentic glomerulonephritis (cGN, n = 11) and chronic interstitial nephritis (n = 13), and in pre-implantation biopsies as controls (n = 8). 20844183 2011
Entrez Id: 958
Gene Symbol: CD40
CD40
0.200 Therapeutic disease RGD Here, we assessed the effects of blocking this pathway using CD40 DNA vaccine enhanced by dendritic cell targeting on the development of active Heymann nephritis, a rat model of human membranous nephropathy. 23223173 2013
Entrez Id: 922
Gene Symbol: CD5L
CD5L
0.010 Biomarker disease BEFREE Predicting risk of pulmonary infection in patients with primary membranous nephropathy on immunosuppressive therapy: The AIM-7C score. 30499223 2019
Entrez Id: 969
Gene Symbol: CD69
CD69
0.010 Biomarker disease BEFREE Predicting risk of pulmonary infection in patients with primary membranous nephropathy on immunosuppressive therapy: The AIM-7C score. 30499223 2019
Entrez Id: 55561
Gene Symbol: CDC42BPG
CDC42BPG
0.010 Biomarker disease BEFREE MALDI-MSI was able to generate molecular signatures of primary and secondary MN, with one particular signal (m/z 1459), identified as Serine/threonine-protein kinase MRCK gamma, being over-expressed in the glomeruli of primary MN patients with respect to secondary MN. 27890680 2017
Entrez Id: 1027
Gene Symbol: CDKN1B
CDKN1B
0.210 Biomarker disease BEFREE We propose that UCH-L1 induces podocyte hypertrophy in MGN by increasing the total protein content through altered degradation and accumulation of proteins such as p27(Kip1) in the cytoplasm of podocytes. 24583340 2014
Entrez Id: 1027
Gene Symbol: CDKN1B
CDKN1B
0.210 Therapeutic disease RGD In human and rat MGN, hypertrophic podocytes exhibited a simultaneous up-regulation of UCH-L1 and of cytoplasmic p27(Kip1) content. 24583340 2014